Literature DB >> 18988706

Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands.

Elena P Sablin1, Raymond D Blind, Irina N Krylova, Jared G Ingraham, Fang Cai, Jon D Williams, Robert J Fletterick, Holly A Ingraham.   

Abstract

Despite the fact that many nuclear receptors are ligand dependent, the existence of obligate regulatory ligands is debated for some receptors, including steroidogenic factor 1 (SF-1). Although fortuitously bound bacterial phospholipids were discovered in the structures of the SF-1 ligand-binding domain (LBD), these lipids might serve merely as structural ligands. Thus, we examined whether exogenously added phospholipids would exchange for these bacterial lipids and bind to SF-1. Here, we report the first crystal structure of the SF-1 LBD bound by the exchanged phosphatidylcholine. Although the bound phosphatidylcholine phospholipid mimics the conformation of bound bacterial phosphoplipids, two surface loops, L2-3 and L11-12, surrounding the entrance to the pocket vary significantly between different SF-1 LBD structures. Based on this observation, we hypothesized that a bound ligand might control the conformations of loops L2-3 and L11-12, and that conserved residues in these dynamic loops could influence ligand binding and the receptor function. Consistent with this hypothesis, impaired phospholipid exchange and diminished transcriptional activity were observed for loop L11-12 SF-1 mutants and for the loop L2-3 human mutant R255L. The endocrine disease associated with this L2-3 mutation coupled with our cellular and biochemical data suggest that critical residues at the mouth of the ligand-binding pocket have evolved for efficient binding of phospholipid ligands and for achieving optimal SF-1 activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18988706      PMCID: PMC2646595          DOI: 10.1210/me.2007-0508

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  22 in total

1.  Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.

Authors:  Lin Lin; Pascal Philibert; Bruno Ferraz-de-Souza; Daniel Kelberman; Tessa Homfray; Assunta Albanese; Veruska Molini; Neil J Sebire; Silvia Einaudi; Gerard S Conway; Ieuan A Hughes; J Larry Jameson; Charles Sultan; Mehul T Dattani; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

2.  The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.

Authors:  Martin B Lee; Lioudmila A Lebedeva; Miyuki Suzawa; Subhagya A Wadekar; Marion Desclozeaux; Holly A Ingraham
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP.

Authors:  Eric A Ortlund; Yoonkwang Lee; Isaac H Solomon; Janet M Hager; Rachid Safi; Yunhee Choi; Ziqiang Guan; Ashutosh Tripathy; Christian R H Raetz; Donald P McDonnell; David D Moore; Matthew R Redinbo
Journal:  Nat Struct Mol Biol       Date:  2005-02-22       Impact factor: 15.369

4.  SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via p300-mediated recruitment to active foci, acetylation, and increased DNA binding.

Authors:  Wei-Yi Chen; Li-Jung Juan; Bon-Chu Chung
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

5.  A comparison of the molecular specificities of whole cell and endonuclear phosphatidylcholine synthesis.

Authors:  Alan N Hunt; Graeme T Clark; James R Neale; Anthony D Postle
Journal:  FEBS Lett       Date:  2002-10-23       Impact factor: 4.124

6.  Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3',5'-monophosphate-dependent cytochrome P450c17 transcription rate.

Authors:  Eric B Dammer; Adam Leon; Marion B Sewer
Journal:  Mol Endocrinol       Date:  2006-11-22

7.  SUMO modification of repression domains modulates function of nuclear receptor 5A1 (steroidogenic factor-1).

Authors:  Wei-Yi Chen; Wen-Chih Lee; Nai-Chi Hsu; Fu Huang; Bon-Chu Chung
Journal:  J Biol Chem       Date:  2004-06-10       Impact factor: 5.157

8.  The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1.

Authors:  Elena P Sablin; April Woods; Irina N Krylova; Peter Hwang; Holly A Ingraham; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-17       Impact factor: 11.205

9.  Partial agonists activate PPARgamma using a helix 12 independent mechanism.

Authors:  John B Bruning; Michael J Chalmers; Swati Prasad; Scott A Busby; Theodore M Kamenecka; Yuanjun He; Kendall W Nettles; Patrick R Griffin
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

10.  SF-1 a key player in the development and differentiation of steroidogenic tissues.

Authors:  Pierre Val; Anne-Marie Lefrançois-Martinez; Georges Veyssière; Antoine Martinez
Journal:  Nucl Recept       Date:  2003-09-18
View more
  40 in total

1.  Time to face the fats: what can mass spectrometry reveal about the structure of lipids and their interactions with proteins?

Authors:  Simon H J Brown; Todd W Mitchell; Aaron J Oakley; Huong T Pham; Stephen J Blanksby
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-06       Impact factor: 3.109

Review 2.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 3.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

Review 4.  Disentangling biological signaling networks by dynamic coupling of signaling lipids to modifying enzymes.

Authors:  Raymond D Blind
Journal:  Adv Biol Regul       Date:  2013-10-18

Review 5.  Nuclear sphingolipid metabolism.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Annu Rev Physiol       Date:  2011-09-09       Impact factor: 19.318

6.  Metabolism: A lipid for fat disorders.

Authors:  Holly A Ingraham
Journal:  Nature       Date:  2011-06-22       Impact factor: 49.962

7.  Annotation of the Nuclear Receptors in an Estuarine Fish species, Fundulus heteroclitus.

Authors:  William S Baldwin; W Tyler Boswell; Gautam Ginjupalli; Elizabeth J Litoff
Journal:  Nucl Receptor Res       Date:  2017

8.  Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.

Authors:  Susan Holbeck; Jianjun Chang; Anne M Best; Angie L Bookout; David J Mangelsdorf; Elisabeth D Martinez
Journal:  Mol Endocrinol       Date:  2010-04-07

9.  Solution Nuclear Magnetic Resonance Studies of the Ligand-Binding Domain of an Orphan Nuclear Receptor Reveal a Dynamic Helix in the Ligand-Binding Pocket.

Authors:  Nicolas Daffern; Zhonglei Chen; Yongbo Zhang; Leslie Pick; Ishwar Radhakrishnan
Journal:  Biochemistry       Date:  2018-03-22       Impact factor: 3.162

Review 10.  Phospholipid--driven gene regulation.

Authors:  Paul M Musille; Jeffrey A Kohn; Eric A Ortlund
Journal:  FEBS Lett       Date:  2013-01-16       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.